0001209191-17-046039.txt : 20170721
0001209191-17-046039.hdr.sgml : 20170721
20170721214939
ACCESSION NUMBER: 0001209191-17-046039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170720
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahatme Sandesh
CENTRAL INDEX KEY: 0001511034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 17977452
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-20
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001511034
Mahatme Sandesh
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, CFO & CBO
Common Stock
2017-07-20
4
M
0
9375
13.71
A
41736
D
Common Stock
2017-07-20
4
S
0
9375
41.00
D
32361
D
Common Stock
2017-07-20
4
M
0
32998
13.90
A
65359
D
Common Stock
2017-07-20
4
S
0
32998
41.00
D
32361
D
Common Stock
2017-07-20
4
M
0
7627
23.85
A
39988
D
Common Stock
2017-07-20
4
S
0
7627
41.00
D
32361
D
Common Stock
2017-07-21
4
M
0
1500
23.85
A
33861
D
Non-Qualified Stock Options (right to buy)
13.71
2017-07-20
4
M
0
9375
13.71
D
2017-02-28
2026-02-28
Common Stock
9375
24591
D
Non-Qualified Stock Options (right to buy)
13.90
2017-07-20
4
M
0
32998
13.90
D
2016-02-27
2025-02-27
Common Stock
32998
56866
D
Non-Qualified Stock Options (right to buy)
23.85
2017-07-20
4
M
0
7627
23.85
D
2013-11-05
2022-11-05
Common Stock
7627
125605
D
Incentive Stock Option (right to buy)
23.85
2017-07-21
4
M
0
1500
23.85
D
2017-02-28
2026-02-28
Common Stock
1500
14268
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 18, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 2, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
25% of the option became exercisable on the first anniversary of the date of hire (11/05/2012) and 1/48th of the total granted option became exercisable on each monthly anniversary thereafter, such that the option became fully exercisable on the fourth anniversary of the date of hire.
/s/David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme
2017-07-21